Exposed Die-Top Encapsulation Molding for an Improved High- Performance Flip Chip BGA Package

The recent advancement in high- performance semiconductor packages has been driven by the need for higher pin count and superior heat dissipation. A one-piece cavity lid flip chip ball grid array (BGA) package with high pin count and targeted reliability has emerged as a popular choice. The flip chip technology can accommodate an I/O count of more than five hundreds500, and the die junction temperature can be reduced to a minimum level by a metal heat spreader attachment. None the less, greater expectations on these high-performance packages arose such as better substrate real estate utilization for multiple chips, ease in handling for thinner core substrates, and improved board- level solder joint reliability. A new design of the flip chip BGA package has been looked into for meeting such requirements. By encapsulating the flip chip with molding compound leaving the die top exposed, a planar top surface can be formed. A, and a flat lid can then be mounted on the planar mold/die top surface. In this manner the direct interaction of the metal lid with the substrate can be removed. The new package is thus less rigid under thermal loading and solder joint reliability enhancement is expected. This paper discusses the process development of the new package and its advantages for improved solder joint fatigue life, and being a multichip package and thin core substrate options. Finite-element simulations have been employed for the study of its structural integrity, thermal, and electrical performances. Detailed package and board-level reliability test results will also be reported     

Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia

OBJECTIVES: The authors describe the relation of provider characteristics to processes, costs, and outcomes of medical care for elderly patients hospitalized for community-acquired pneumonia. METHODS: Using Medicare claims data, Medicare beneficiaries discharged from Pennsylvania hospitals during 1990 with community-acquired pneumonia were identified. Claims data were used to ascertain mortality, readmissions, use of procedures and physician consultations, and the costs of care. The relationship of these measures to provider characteristics was analyzed using regression techniques to adjust for patient characteristics, including comorbidity and microbial etiology. RESULTS: Among 22,294 pneumonia episodes studied, 30-day mortality was 17.0%. After adjusting for patient characteristics, 30-day mortality and readmission rates were unrelated to hospital teaching status or urban location or to physician specialty. Use of procedures and physician consultations was more common and costs were 11% higher among patients discharged from teaching hospitals compared with nonteaching hospitals. Similarly, costs were 15% higher at urban hospitals compared with rural hospitals. General internists and medical subspecialists used more procedures and had higher costs than family practitioners. CONCLUSIONS: Processes and costs of care for community-acquired pneumonia varied by provider characteristics, but neither mortality nor readmission rates did. These differences cannot be explained by clinical variables in the database. Further studies should determine whether less costly patterns of care for pneumonia, and perhaps other conditions, could replace more costly ones without compromising patient outcomes.     

Victim retention for reducing cache misses in tiled chip multiprocessors

This paper presents CMP-VR (Chip-Multiprocessor with Victim Retention), an approach to improve cache performance by reducing the number of off-chip memory accesses. The objective of this approach is to retain the chosen victim cache blocks on the chip for the longest possible time. It may be possible that some sets of the CMPs last level cache (LLC) are heavily used, while certain others are not. In CMP-VR, some number of ways from every set are used as reserved storage. It allows a victim block from a heavily used set to be stored into the reserve space of another set. In this way the load of heavily used sets are distributed among the underused sets. This logically increases the associativity of the heavily used sets without increasing the actual associativity and size of the cache. Experimental evaluation using full-system simulation shows that CMP-VR has less off-chip miss-rate as compared to baseline Tiled CMP. Results are presented for different cache sizes and associativity for CMP-VR and baseline configuration. The best improvements obtained are 45.5% and 14% in terms of miss rate and cycles per instruction (CPI) respectively for a 4 MB, 4-way set associative LLC. Reduction in CPI and miss rate together guarantees performance improvement.     

A reclaimer scheduling problem arising in coal stockyard management

We study a number of variants of an abstract scheduling problem inspired by the scheduling of reclaimers in the stockyard of a coal export terminal. We analyze the complexity of each of the variants, providing complexity proofs for some and polynomial algorithms for others. For one, especially interesting variant, we also develop a constant factor approximation algorithm.     

Catalytic oxidation of carbon monoxide over radiolytically prepared Pt nanoparticles supported on glass

Platinum nanoparticles have been prepared by radiolytic and chemical methods in the presence of stabilizer gelatin and SiO₂ nanoparticles. The formation of Pt nanoparticles was confirmed using UV-vis absorption spectroscopy and transmission electron microscopy (TEM). The prepared particles were coated on the inner walls of the tubular pyrex reactor and tested for their catalytic activity for oxidation of CO. It was observed that Pt nanoparticles prepared in the presence of a stabilizer (gelatin) showed a higher tendency to adhere to the inner walls of the pyrex reactor as compared to that prepared in the presence of silica nanoparticles. The catalyst was found to be active at ≥150 °C giving CO₂. Chemically reduced Pt nanoparticles stabilized on silica nanoparticles gave ∼7% CO conversion per hour. However, radiolytically prepared Pt nanoparticles stabilized by gelatin gave ∼10% conversion per hour. Catalytic activity of radiolytically prepared platinum catalyst, coated on the inner walls of the reactor, was evaluated as a function of CO concentration and reaction temperature. The rate of reaction increased with increase in reaction temperature and the activation energy for the reaction was found to be ∼108.8 kJ mol⁻¹. The rate of CO₂ formation was almost constant (∼1.5 × 10⁻⁴ mol dm⁻³ h⁻¹) at constant O₂ concentration (6.5 × 10⁻³ mol dm⁻³) with increase in CO concentration from 2 × 10⁻⁴ mol dm⁻³ to 3.25 × 10⁻³ mol dm⁻³. The data indicate that catalytic oxidation of CO takes place by Eley-Rideal mechanism.     

Modelling and verification of delay-insensitive circuits using CCS and the Concurrency Workbench

The modelling of delay-insensitive asynchronous circuits in the process calculus CCS is addressed. MUST-testing (rather than bisimulation) is found to support verification both of the property of delay-insensitivity and of design by stepwise refinement. Automated verification is possible with a well-known tool, the Edinburgh Concurrency Workbench.     

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY STUDIES OF SEDIMENTS DERIVED FROM VISBROKEN RESIDUES: STABILITY STUDIES.

The ¹H and ¹³C n.m.r analysis of the sediments derived from visbroken short residues (150°C+) obtained at different severity levels is reported. The nature of sediments and structural changes during visbreaking and on storage at ambient conditions are related to the processing characteristics of the residual fuel oils. The possible relationship between storage stability and processing conditions is also discussed.     

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines

CONTEXT: Many groups have developed guidelines to shorten hospital length of stay in pneumonia in order to decrease costs, but the length of time until a patient hospitalized with pneumonia becomes clinically stable has not been established. OBJECTIVE: To describe the time to resolution of abnormalities in vital signs, ability to eat, and mental status in patients with community-acquired pneumonia and assess clinical outcomes after achieving stability. DESIGN: Prospective, multicenter, observational cohort study. SETTING: Three university and 1 community teaching hospital in Boston, Mass, Pittsburgh, Pa, and Halifax, Nova Scotia. PATIENTS: Six hundred eighty-six adults hospitalized with community-acquired pneumonia. MAIN OUTCOME MEASURES: Time to resolution of vital signs, ability to eat, mental status, hospital length of stay, and admission to an intensive care, coronary care, or telemetry unit. RESULTS: The median time to stability was 2 days for heart rate (< or =100 beats/min) and systolic blood pressure (> or =90 mm Hg), and 3 days for respiratory rate (< or =24 breaths/min), oxygen saturation (> or =90%), and temperature (< or =37.2 degrees C [99 degrees F]). The median time to overall clinical stability was 3 days for the most lenient definition of stability and 7 days for the most conservative definition. Patients with more severe cases of pneumonia at presentation took longer to reach stability. Once stability was achieved, clinical deterioration requiring intensive care, coronary care, or telemetry monitoring occurred in 1% of cases or fewer. Between 65% to 86% of patients stayed in the hospital more than 1 day after reaching stability, and fewer than 29% to 46% were converted to oral antibiotics within 1 day of stability, depending on the definition of stability. CONCLUSIONS: Our estimates of time to stability in pneumonia and explicit criteria for defining stability can provide an evidence-based estimate of optimal length of stay, and outline a clinically sensible approach to improving the efficiency of inpatient management.     

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates

Adenosine deaminase-deficient severe combined immunodeficiency was the first disease investigated for gene therapy because of a postulated production or survival advantage for gene-corrected T lymphocytes, which may overcome inefficient gene transfer. Four years after three newborns with this disease were given infusions of transduced autologous umbilical cord blood CD34+ cells, the frequency of gene-containing T lymphocytes has risen to 1-10%, whereas the frequencies of other hematopoietic and lymphoid cells containing the gene remain at 0.01-0.1%. Cessation of polyethylene glycol-conjugated adenosine deaminase enzyme replacement in one subject led to a decline in immune function, despite the persistence of gene-containing T lymphocytes. Thus, despite the long-term engraftment of transduced stem cells and selective accumulation of gene-containing T lymphocytes, improved gene transfer and expression will be needed to attain a therapeutic effect.     

Enhancement in the limit of detection of lab-on-chip microfluidic devices using functional nanomaterials

Technological developments in recent years have witnessed a paradigm shift towards lab-on-chip devices for various diagnostic applications. Lab-on-chip technology integrates several functions typically performed in a large-scale analytical laboratory on a small-scale platform. These devices are more than the miniaturized versions of conventional analytical and diagnostic techniques. The advances in fabrication techniques, material sciences, surface modification strategies, and their integration with microfluidics and chemical and biological-based detection mechanisms have enormously enhanced the capabilities of these devices. The minuscule sample and reagent requirements, capillary-driven pump-free flows, faster transport phenomena, and ease of integration with various signal readout mechanisms make these platforms apt for use in resource-limited settings, especially in developing and underdeveloped parts of the world. The microfluidic lab-on-a-chip technology offers a promising approach to developing cost-effective and sustainable point-of-care testing applications. Numerous merits of this technology have attracted the attention of researchers to develop low-cost and rapid diagnostic platforms in human healthcare, veterinary medicine, food quality testing, and environmental monitoring. However, one of the major challenges associated with these devices is their limited sensitivity or the limit of detection. The use of functional nanomaterials in lab-on-chip microfluidic devices can improve the limit of detection by enhancing the signal-to-noise ratio, increasing the capture efficiency, and providing capabilities for devising novel detection schemes. This review presents an overview of state-of-the-art techniques for integrating functional nanomaterials with microfluidic devices and discusses the potential applications of these devices in various fields.